Nephrology and Kidney Diseases

Dialysis remains a life-sustaining therapy for patients with advanced kidney failure, requiring both technical expertise and patient-centered care. This session provides a comprehensive overview of hemodialysis and peritoneal dialysis, focusing on modality selection, initiation timing, and long-term management. Participants will learn about dialysis adequacy, access management, infection prevention, and handling common complications such as hypotension, cramps, and electrolyte disturbances. The session also explores advancements in dialysis technology, home-based dialysis models, and strategies to improve treatment efficiency and patient comfort. Emphasis is placed on improving quality of life through individualized care plans, nutritional support, and psychosocial management. Future trends in dialysis delivery and innovations shaping renal replacement therapy are also discussed.

Chronic Kidney Disease (CKD) is one of the fastest-growing non-communicable diseases worldwide and a major contributor to long-term morbidity, mortality, and healthcare costs. This session delivers a deep yet practical understanding of CKD, focusing on early identification, accurate staging, and timely intervention to delay disease progression. Participants will gain insights into key risk factors such as diabetes, hypertension, cardiovascular disorders, lifestyle habits, and genetic predisposition. The session emphasizes real-world clinical management, including guideline-based pharmacotherapy, blood pressure and metabolic control, and renoprotective strategies. Special attention is given to managing CKD-related complications such as anemia, bone and mineral disorders, electrolyte imbalance, and cardiovascular risk. Nutritional counseling, patient adherence, and quality-of-life improvement are also discussed. Emerging biomarkers, innovative drug therapies, and personalized treatment approaches are explored to highlight the future direction of CKD care. This session aims to empower healthcare professionals with actionable knowledge to improve patient outcomes and reduce the long-term burden of chronic kidney disease.

Acute Kidney Injury (AKI) is a sudden and often reversible decline in kidney function that remains a critical challenge in both hospital and intensive care settings. This session focuses on improving early recognition, rapid diagnosis, and effective management of AKI to prevent long-term renal damage and mortality. Participants will explore common and emerging causes of AKI, including sepsis, dehydration, nephrotoxic drugs, surgical complications, and contrast exposure. The session highlights modern diagnostic tools, including novel biomarkers and risk prediction models, enabling earlier intervention. Evidence-based management strategies such as fluid optimization, electrolyte correction, medication adjustment, and timely renal replacement therapy are discussed in detail. Special focus is given to AKI in critically ill patients, postoperative care, and prevention strategies in high-risk populations. By strengthening clinical decision-making, this session aims to improve recovery rates, reduce complications, and enhance patient survival.

High blood pressure is both a leading cause and consequence of kidney disease, profoundly impacting long-term renal and cardiovascular outcomes. This session explores the intricate relationship between hypertension and kidney dysfunction, emphasizing early detection, risk stratification, and evidence-based management. Participants will review pharmacological strategies, including ACE inhibitors, ARBs, and newer therapeutic options, alongside lifestyle interventions such as diet modification, exercise, and weight control. Special attention is given to resistant hypertension, secondary causes, and individualized blood pressure targets for CKD and transplant patients. By combining clinical insights with practical recommendations, this session empowers healthcare professionals to optimize blood pressure management and slow kidney disease progression.

Kidney diseases in children present unique challenges due to developmental and congenital factors. This session focuses on common pediatric renal conditions, including congenital anomalies, hereditary disorders, nephrotic syndrome, and acute kidney injury. Early diagnosis, age-appropriate treatment strategies, growth and development considerations, and long-term follow-up are emphasized. Sessions will also cover family-centered care, transition to adult nephrology, and strategies to improve adherence and outcomes in pediatric patients. This session equips clinicians and pediatric specialists with actionable strategies for effective renal care in children.

Kidney dysfunction in critically ill patients is a frequent complication with serious consequences. This session explores acute kidney injury in ICU settings, sepsis-associated renal injury, and multi-organ failure. Participants will learn evidence-based strategies for fluid management, electrolyte and acid–base balance, and continuous renal replacement therapies (CRRT). Emphasis is placed on early recognition, risk assessment, and multidisciplinary collaboration to improve survival and minimize long-term renal damage. Practical case studies and real-world approaches will help participants apply knowledge directly in critical care settings.

Personalized medicine is transforming the landscape of kidney care. This session examines cutting-edge therapies, including biologics, gene-based treatments, and targeted drug delivery systems. Attendees will learn how to tailor therapy based on genetic, molecular, and clinical profiles to maximize efficacy and minimize side effects. Practical case examples demonstrate the application of precision medicine in CKD, AKI, and transplant patients. Future directions in individualized renal care and innovative treatment strategies are discussed to equip clinicians with the knowledge to implement advanced therapies.

Preventing kidney disease is as important as treating it. This session explores population-based strategies, early screening programs, lifestyle interventions, and community awareness initiatives. Participants will learn how public health programs, policy initiatives, and preventive healthcare models can reduce the global burden of CKD and related complications. The session also highlights risk reduction strategies for high-risk populations, emphasizing actionable measures that healthcare providers can implement in clinical and community settings to improve outcomes.

Kidney disease in older adults presents unique challenges due to comorbidities, physiological changes, and increased vulnerability. This session focuses on diagnosing, managing, and monitoring renal disorders in elderly patients. Polypharmacy, frailty, and ethical decision-making are explored, alongside strategies to maintain quality of life and independence. Participants will learn approaches for individualized treatment, medication adjustment, and risk reduction in geriatric populations, ensuring safe and effective kidney care in aging patients.

Acute renal emergencies require rapid assessment and intervention to prevent irreversible damage and life-threatening complications. This session focuses on sudden renal failure, electrolyte disturbances, hyperkalemia, severe dehydration, and other urgent kidney-related conditions. Participants will gain practical knowledge on early recognition, triage, and evidence-based interventions, including fluid resuscitation, renal replacement therapy, and monitoring strategies. The session emphasizes multidisciplinary coordination, critical decision-making, and real-world case studies to enhance preparedness in managing acute kidney complications effectively and safely.

Nutrition is a cornerstone of kidney health and disease management. This session covers dietary interventions for patients across all stages of kidney disease, including protein, sodium, potassium, and phosphate management. Participants will learn strategies for individualized meal planning, nutritional support during dialysis, and prevention of malnutrition and metabolic complications. The session emphasizes practical, evidence-based guidance to support patient adherence, enhance quality of life, and slow disease progression.

Kidney diseases are increasingly recognized as having significant genetic contributions, from congenital anomalies to hereditary nephropathies. This session explores advances in renal genetics, including gene mutations linked to CKD, polycystic kidney disease, and rare hereditary disorders. Participants will learn how genetic testing can guide early diagnosis, risk assessment, and personalized treatment plans. Practical strategies for integrating genetic insights into routine clinical practice are discussed, including family screening, counseling, and ethical considerations. Emphasis is placed on how precision medicine combined with genomics is shaping individualized kidney care, improving patient outcomes, and preventing disease progression.

Autoimmune and immunologically mediated kidney diseases, such as lupus nephritis, IgA nephropathy, and vasculitis, pose diagnostic and therapeutic challenges. This session provides a comprehensive understanding of immune system involvement in renal pathology. Discussions cover early detection through serological markers, biopsy interpretation, and disease monitoring. Evidence-based management strategies, including immunosuppressive therapies and novel biologics, are emphasized. The session also explores long-term monitoring, relapse prevention, and the balance between efficacy and adverse effects. Attendees gain insights into tailoring treatments to individual patient profiles for optimal disease control.

Kidney stones are a common and recurrent renal disorder with significant morbidity. This session focuses on the pathophysiology, risk factors, and prevention strategies for urolithiasis. Participants will learn about the latest diagnostic modalities, including imaging and metabolic evaluation, as well as advanced treatment options such as minimally invasive surgery, lithotripsy, and pharmacologic management. Nutrition, hydration, and lifestyle modifications for recurrence prevention are also discussed. The session aims to equip clinicians with comprehensive knowledge to manage acute episodes, prevent recurrence, and improve patient quality of life.

The connection between diabetes and kidney disease is a leading cause of CKD globally. This session emphasizes integrated care strategies for diabetic nephropathy, combining glycemic control, blood pressure management, and renoprotective therapies. Participants will learn to use modern antidiabetic medications that also benefit renal outcomes, such as SGLT2 inhibitors and GLP-1 receptor agonists. Early detection, risk stratification, patient education, and multidisciplinary collaboration are highlighted. Practical approaches for slowing disease progression and preventing complications are a central focus, making this session valuable for endocrinologists, nephrologists, and primary care providers alike.

Cancer therapies can significantly affect kidney function, leading to acute or chronic injury. This session focuses on the emerging field of onco-nephrology, addressing renal complications from chemotherapy, immunotherapy, and targeted agents. Participants will learn to balance cancer treatment efficacy with kidney protection, manage drug-induced nephrotoxicity, and monitor high-risk patients. Evidence-based strategies for hydration, dose adjustment, and renal replacement therapy are discussed. The session highlights interdisciplinary collaboration between oncologists, nephrologists, and critical care specialists to optimize both renal and oncologic outcomes.

Cardiometabolic disorders such as obesity, hypertension, and diabetes have a profound impact on kidney health. This session explores the intersection of metabolic syndrome and renal disease, highlighting mechanisms of injury, risk prediction, and management strategies. Participants will gain insights into lifestyle interventions, pharmacotherapy, and preventive measures tailored to at-risk populations. Emphasis is placed on integrated, patient-centered care to reduce CKD incidence, slow progression, and improve overall cardiometabolic health.

Technology is transforming the diagnosis, monitoring, and treatment of kidney diseases. This session explores AI-driven decision support, predictive analytics for CKD progression, remote monitoring, and digital tools for dialysis and transplant management. Participants will learn how data integration, machine learning, and wearable devices are enhancing patient outcomes and optimizing healthcare delivery. Case studies demonstrate practical applications, including early detection, risk stratification, and personalized treatment planning. This session prepares nephrology professionals to leverage technology for smarter, more efficient, and precise kidney care.

Kidney infections and urinary tract disorders are common conditions that, if left untreated, can lead to serious complications including sepsis and long-term kidney damage. This session provides a comprehensive overview of bacterial, viral, and fungal infections affecting the kidneys, with a focus on diagnosis, treatment, and prevention. Participants will learn about risk factors, antibiotic stewardship, imaging and laboratory investigations, and management strategies for recurrent or complicated infections. Special attention is given to urinary tract obstruction, vesicoureteral reflux, and strategies to preserve renal function. Case discussions highlight real-world approaches, emphasizing timely intervention and integrated care for improved patient outcomes.